PERM1
gene geneOn this page
Also known as MGC13275RP11-54O7.8
Summary
PERM1 (PPARGC1 and ESRR induced regulator, muscle 1, HGNC:28208) is a protein-coding gene on chromosome 1p36.33, encoding PGC-1 and ERR-induced regulator in muscle protein 1 (Q5SV97). Regulates the expression of selective PPARGC1A/B and ESRRA/B/G target genes with roles in glucose and lipid metabolism, energy transfer, contractile function, muscle mitochondrial biogenesis and oxidative capacity.
Involved in response to muscle activity. Predicted to be active in cytoplasm and nucleus.
Source: NCBI Gene 84808 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 9 total
- MANE Select transcript:
NM_001394713
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28208 |
| Approved symbol | PERM1 |
| Name | PPARGC1 and ESRR induced regulator, muscle 1 |
| Location | 1p36.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC13275, RP11-54O7.8 |
| Ensembl gene | ENSG00000187642 |
| Ensembl biotype | protein_coding |
| OMIM | 615921 |
| Entrez | 84808 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 11 protein_coding, 1 retained_intron
ENST00000341290, ENST00000433179, ENST00000479361, ENST00000694917, ENST00000880867, ENST00000880868, ENST00000880869, ENST00000880870, ENST00000959770, ENST00000959771, ENST00000959772, ENST00000959773
RefSeq mRNA: 5 — MANE Select: NM_001394713
NM_001291366, NM_001291367, NM_001369897, NM_001369898, NM_001394713
CCDS: CCDS76083, CCDS90836
Canonical transcript exons
ENST00000433179 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001389758 | 978881 | 981173 |
| ENSE00002263633 | 976499 | 976624 |
| ENSE00003728856 | 982065 | 982093 |
| ENSE00003963238 | 975198 | 976269 |
Expression profiles
Bgee: expression breadth ubiquitous, 153 present calls, max score 98.49.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6924 / max 125.5523, expressed in 60 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 9674 | 0.5162 | 52 |
| 9675 | 0.1047 | 32 |
| 9673 | 0.0715 | 27 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 98.49 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 98.00 | gold quality |
| gastrocnemius | UBERON:0001388 | 96.28 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 95.76 | silver quality |
| heart left ventricle | UBERON:0002084 | 95.40 | gold quality |
| cardiac ventricle | UBERON:0002082 | 95.13 | gold quality |
| muscle of leg | UBERON:0001383 | 94.18 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 92.18 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 91.80 | gold quality |
| right atrium auricular region | UBERON:0006631 | 91.54 | gold quality |
| cardiac atrium | UBERON:0002081 | 91.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 89.84 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 89.09 | gold quality |
| vastus lateralis | UBERON:0001379 | 88.81 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 88.65 | gold quality |
| body of tongue | UBERON:0011876 | 87.88 | gold quality |
| quadriceps femoris | UBERON:0001377 | 87.48 | silver quality |
| heart | UBERON:0000948 | 86.91 | gold quality |
| parotid gland | UBERON:0001831 | 86.61 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 85.13 | gold quality |
| heart right ventricle | UBERON:0002080 | 84.92 | silver quality |
| muscle tissue | UBERON:0002385 | 84.63 | gold quality |
| biceps brachii | UBERON:0001507 | 84.28 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 82.81 | gold quality |
| upper arm skin | UBERON:0004263 | 82.73 | gold quality |
| tongue | UBERON:0001723 | 82.43 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 79.62 | gold quality |
| vena cava | UBERON:0004087 | 78.68 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 78.66 | gold quality |
| buccal mucosa cell | CL:0002336 | 76.46 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.53 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting PERM1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3942-3P | 99.57 | 69.03 | 2854 |
| HSA-MIR-532-3P | 99.34 | 65.76 | 1195 |
| HSA-MIR-5197-3P | 98.71 | 67.05 | 1905 |
| HSA-MIR-423-5P | 98.69 | 67.48 | 1522 |
| HSA-MIR-767-3P | 98.61 | 67.69 | 1192 |
| HSA-MIR-4290 | 98.51 | 65.17 | 907 |
| HSA-MIR-2117 | 98.48 | 67.97 | 1307 |
| HSA-MIR-6514-3P | 97.52 | 66.50 | 808 |
| HSA-MIR-214-5P | 97.34 | 66.50 | 617 |
| HSA-MIR-6859-3P | 97.26 | 64.69 | 428 |
| HSA-MIR-4286 | 97.20 | 64.37 | 1587 |
| HSA-MIR-4662A-3P | 97.02 | 67.77 | 941 |
| HSA-MIR-4689 | 96.97 | 65.79 | 1209 |
| HSA-MIR-500B-3P | 96.49 | 65.40 | 1087 |
| HSA-MIR-4701-5P | 96.45 | 68.41 | 1121 |
| HSA-MIR-6858-5P | 96.05 | 64.59 | 1020 |
Literature-anchored findings (GeneRIF, showing 3)
- Proteomics evidence was identified for the PERM1 gene (PMID:24870542)
- These findings identify Perm1 as a muscle-specific regulator of exercise-induced signaling and Perm1 levels as tuners of the skeletal muscle response to exercise. (PMID:30862473)
- Perm1 regulates cardiac energetics as a downstream target of the histone methyltransferase Smyd1. (PMID:32574189)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | perm1b | ENSDARG00000076850 |
| mus_musculus | Perm1 | ENSMUSG00000078486 |
| rattus_norvegicus | Perm1 | ENSRNOG00000020244 |
Paralogs (1): PRRT3 (ENSG00000163704)
Protein
Protein identifiers
PGC-1 and ERR-induced regulator in muscle protein 1 — Q5SV97 (reviewed: Q5SV97)
Alternative names: PPARGC1 and ESRR-induced regulator in muscle 1, Peroxisome proliferator-activated receptor gamma coactivator 1 and estrogen-related receptor-induced regulator in muscle 1
All UniProt accessions (1): Q5SV97
UniProt curated annotations — full annotation on UniProt →
Function. Regulates the expression of selective PPARGC1A/B and ESRRA/B/G target genes with roles in glucose and lipid metabolism, energy transfer, contractile function, muscle mitochondrial biogenesis and oxidative capacity. Required for the efficient induction of MT-CO2, MT-CO3, COX4I1, TFB1M, TFB2M, POLRMT and SIRT3 by PPARGC1A. Positively regulates the PPARGC1A/ESRRG-induced expression of CKMT2, TNNI3 and SLC2A4 and negatively regulates the PPARGC1A/ESRRG-induced expression of PDK4.
Subcellular location. Cytoplasm. Nucleus.
Tissue specificity. Muscle-specific expression is increased by endurance exercise.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5SV97-1 | 1 | yes |
| Q5SV97-2 | 2 | |
| Q5SV97-3 | 3 |
RefSeq proteins (5): NP_001278295, NP_001278296, NP_001356826, NP_001356827, NP_001381642* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR043442 | Perm1 | Family |
UniProt features (22 total): compositionally biased region 10, sequence conflict 5, region of interest 4, splice variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5SV97-F1 | 44.94 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-2151201 | Transcriptional activation of mitochondrial biogenesis |
MSigDB gene sets: 15 (showing top):
GOBP_RESPONSE_TO_MUSCLE_ACTIVITY, GOBP_RESPONSE_TO_ACTIVITY, RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP, chr1p36, YANG_BCL3_TARGETS_UP, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, REACTOME_MITOCHONDRIAL_BIOGENESIS, REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE, REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS, RYBP_TARGET_GENES, MIR3942_3P, GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN, HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP, WP_1P36_COPY_NUMBER_VARIATION_SYNDROME, GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP
GO Biological Process (2): regulation of DNA-templated transcription (GO:0006355), response to muscle activity (GO:0014850)
GO Molecular Function (0):
GO Cellular Component (2): nucleus (GO:0005634), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial biogenesis | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| response to activity | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1040 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PERM1 | ANK2 | Q01484 | 445 |
| PERM1 | TFB2M | Q9H5Q4 | 425 |
| PERM1 | KRTAP10-3 | P60369 | 418 |
| PERM1 | ESRRG | P62508 | 406 |
| PERM1 | ESRRA | P11474 | 385 |
| PERM1 | PPARGC1A | Q9UBK2 | 364 |
| PERM1 | NDUFAF7 | Q7L592 | 356 |
| PERM1 | NDUFAF2 | Q8N183 | 353 |
| PERM1 | TTC16 | Q8NEE8 | 331 |
| PERM1 | SLC7A1 | P30825 | 328 |
| PERM1 | TMEM41A | Q96HV5 | 325 |
| PERM1 | CREG1 | O75629 | 317 |
| PERM1 | MICOS13 | Q5XKP0 | 307 |
| PERM1 | HRC | P23327 | 306 |
| PERM1 | TTLL11 | Q8NHH1 | 304 |
IntAct
0 interactions, top by confidence:
BioGRID (2): PERM1 (Two-hybrid), PERM1 (Protein-peptide)
ESM2 similar proteins: A0A0J9YX94, A0A0J9YXQ4, A0A0J9YY54, A0A494C1R9, A5D7L8, A6NDY0, A6NKD2, A7E321, E9PGG2, F6SZT2, O14771, O19110, O75807, O88852, P0CV98, P0CV99, P0CW00, P0CW01, P0CW24, P17564, P78358, Q01534, Q0P5N2, Q15735, Q2KI51, Q2M329, Q587J8, Q5DTT8, Q5R5G8, Q5R6R8, Q5SV97, Q60465, Q62881, Q69ZB3, Q6P752, Q86V59, Q8BSI6, Q8IWY8, Q8N3D4, Q8VD63
Diamond homologs: A5D7L8, Q149B8, Q5SV97
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
9 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 8 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
451 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:976265:CAAGG:C | acceptor_gain | 0.9900 |
| 1:976270:C:CC | acceptor_gain | 0.9900 |
| 1:976266:AAGG:A | acceptor_gain | 0.9800 |
| 1:976267:AGG:A | acceptor_gain | 0.9800 |
| 1:976268:GG:G | acceptor_gain | 0.9800 |
| 1:976268:GGCTG:G | acceptor_loss | 0.9700 |
| 1:976269:GCTGC:G | acceptor_loss | 0.9700 |
| 1:976270:C:CA | acceptor_loss | 0.9700 |
| 1:976271:T:G | acceptor_loss | 0.9700 |
| 1:978876:CGTA:C | donor_loss | 0.9400 |
| 1:978877:GTA:G | donor_loss | 0.9400 |
| 1:978878:TACCT:T | donor_loss | 0.9400 |
| 1:978879:A:C | donor_loss | 0.9400 |
| 1:978880:C:CT | donor_loss | 0.9400 |
| 1:979020:AAG:A | donor_gain | 0.9400 |
| 1:978353:T:TA | donor_gain | 0.9200 |
| 1:978875:ACGT:A | donor_loss | 0.9200 |
| 1:978883:G:A | donor_gain | 0.9200 |
| 1:976272:G:C | acceptor_loss | 0.9100 |
| 1:978281:TAAGA:T | donor_gain | 0.9000 |
| 1:979015:C:CA | donor_gain | 0.9000 |
| 1:978879:ACCTG:A | donor_gain | 0.8900 |
| 1:978880:CCTGC:C | donor_gain | 0.8900 |
| 1:979145:TCG:T | donor_gain | 0.8800 |
| 1:978874:CACGT:C | donor_loss | 0.8700 |
| 1:979051:TAG:T | donor_gain | 0.8700 |
| 1:979052:AGA:A | donor_gain | 0.8700 |
| 1:978289:A:C | donor_gain | 0.8600 |
| 1:979146:CG:C | donor_gain | 0.8600 |
| 1:976273:CAAGA:C | acceptor_loss | 0.8400 |
AlphaMissense
5038 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:976508:A:G | W756R | 0.990 |
| 1:976508:A:T | W756R | 0.990 |
| 1:980976:G:C | F18L | 0.987 |
| 1:980976:G:T | F18L | 0.987 |
| 1:980978:A:G | F18L | 0.987 |
| 1:976506:C:A | W756C | 0.985 |
| 1:976506:C:G | W756C | 0.985 |
| 1:980985:C:A | W15C | 0.983 |
| 1:980985:C:G | W15C | 0.983 |
| 1:976503:T:A | K757N | 0.981 |
| 1:976503:T:G | K757N | 0.981 |
| 1:980977:A:G | F18S | 0.981 |
| 1:976504:T:A | K757I | 0.980 |
| 1:976547:A:G | W743R | 0.979 |
| 1:976547:A:T | W743R | 0.979 |
| 1:976552:G:T | A741D | 0.978 |
| 1:979512:G:C | F506L | 0.978 |
| 1:979512:G:T | F506L | 0.978 |
| 1:979514:A:G | F506L | 0.978 |
| 1:976563:A:C | F737L | 0.976 |
| 1:976563:A:T | F737L | 0.976 |
| 1:976565:A:G | F737L | 0.976 |
| 1:976545:C:A | W743C | 0.975 |
| 1:976545:C:G | W743C | 0.975 |
| 1:981018:G:C | F4L | 0.973 |
| 1:981018:G:T | F4L | 0.973 |
| 1:981020:A:G | F4L | 0.973 |
| 1:979272:G:C | F586L | 0.972 |
| 1:979272:G:T | F586L | 0.972 |
| 1:979274:A:G | F586L | 0.972 |
dbSNP variants (sampled 300 via entrez): RS1000018442 (1:982715 G>A), RS1000120877 (1:984068 G>A), RS1000608524 (1:979181 C>G,T), RS1001211743 (1:978338 G>A), RS1001523923 (1:978641 T>G), RS1001933039 (1:976476 C>T), RS1002221772 (1:981742 C>G), RS1002758216 (1:983563 G>A), RS1002896665 (1:976642 C>A,T), RS1003193701 (1:976714 A>C,G,T), RS1003324615 (1:983760 A>T), RS1003863211 (1:981067 G>A,T), RS1004002700 (1:975682 C>T), RS1004017158 (1:981836 G>A), RS1004115582 (1:976099 G>A)
Disease associations
OMIM: gene MIM:615921 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008513_1 | Health literacy | 6.000000e-06 |
| GCST010241_352 | Apolipoprotein A1 levels | 2.000000e-11 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010104 | health literacy measurement |
| EFO:0004614 | apolipoprotein A 1 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression | 2 |
| methyleugenol | decreases expression | 1 |
| kojic acid | decreases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| beta-lapachone | increases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arbutin | decreases expression | 1 |
| Estradiol | increases expression, affects cotreatment | 1 |
| Folic Acid | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.